Hydrochloric Acid

Hydrochloric Acid

SCHEMBL988663

COC(=N)CCCCCC(=O)OC.Cl

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
POLA1 known ✓ P09884 1/20 0.39
TSHR P16473 3/20 0.58
LMNA P02545 3/20 0.52
ALDH1A1 P00352 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
HPGD P15428 1/20 0.42
KDM4E B2RXH2 1/20 0.42
RECQL P46063 1/20 0.42
EPHX2 P34913 4/20 0.40
POLB P06746 1/20 0.39
CA12 O43570 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL351072 1.00 TSHR (0.58) TSHRLMNAALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL3613959 1.00 TSHR (0.58) TSHRLMNAALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL164305 1.00 TSHR (0.58) TSHRLMNAALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL120844 0.98 TSHR (0.61) TSHRLMNAALDH1A1L3MBTL1KMT2A
SCHEMBL44285 0.98 TSHR (0.61) TSHRLMNAALDH1A1L3MBTL1KMT2A
SCHEMBL43894 0.98 TSHR (0.61) TSHRLMNAALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL1266800 0.98 TSHR (0.61) TSHRLMNAALDH1A1L3MBTL1KMT2A
SCHEMBL44179 0.96 TSHR (0.64) TSHRLMNAALDH1A1L3MBTL1KMT2A
SCHEMBL328732 0.93 TSHR (0.61) TSHRLMNAALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL988664 0.86 SPHK2 (0.35) TSHRLMNAALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871776-B2 Compositions and methods for enhancing the identification of prior protein PrPSc TRUSTEES OF DARTMOUTH COLLEGE (US) 2011-01-18 US disclosed
US-20100233763-A1 DUAL-SIDED THERMAL CYCLER APPLIED BIOSYSTEMS, LLC (US) 2010-09-16 US disclosed
US-20090325277-A1 Thermal Device, System, and Method, for Fluid Processing Device APPLIED BIOSYSTEMS, LLC (US) 2009-12-31 US disclosed
US-7585663-B2 Thermal device, system, and method, for fluid processing device APPLIED BIOSYSTEMS, LLC (US) 2009-09-08 US disclosed
US-7491363-B2 Fluid processing device APPLIED BIOSYSTEMS, LLC. (US) 2009-02-17 US disclosed
US-20080261316-A1 Compositions and Methods For Enhancing the Identification of Prior Protein Prpsc NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-10-23 US disclosed
US-7407760-B2 Compositions and methods for enhancing the identification of prion protein PRPSc TRUSTEES OF DARTMOUTH COLLEGE (US) 2008-08-05 US disclosed
WO-2007082173-A2 COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPSC TRUSTEES OF DARTMOUTH COLLEGE (US) 2007-07-19 WO disclosed
EP-1789781-A2 THERMAL DEVICE, SYSTEM, AND METHOD, FOR FLUID PROCESSING DEVICE Applera Corporation (US) 2007-05-30 EP disclosed
US-20060127888-A1 Compositions and methods for enhancing the identification of prion protein PRPsc NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-06-15 US disclosed
WO-2006025929-A2 THERMAL DEVICE, SYSTEM, AND METHOD, FOR FLUID PROCESSING DEVICE APPLERA CORPORATION (US) 2006-03-09 WO disclosed
US-20060046304-A1 Thermal device, system, and method, for fluid processing device APPLERA CORPORATION (US) 2006-03-02 US disclosed
WO-2006019500-A2 FLUID PROCESSING DEVICE APPLERA CORPORATION (US) 2006-02-23 WO disclosed
US-20060013741-A1 Fluid processing device APPLERA CORPORATION (US) 2006-01-19 US disclosed
EP-1252172-A2 COMPOUND COMPRISING A PEPTIDE MOIETY AND AN ORGANO-SILANE MOIETY VBC-Genomics Bioscience Research GmbH (AT) 2002-10-30 EP disclosed
WO-2001046213-A2 COMPOUND COMPRISING A PEPTIDE MOIETY AND AN ORGANO-SILANE MOIETY. VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AT) 2001-06-28 WO disclosed
US-6066319-A Drug delivery using terminal complement components PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2000-05-23 US disclosed
US-5053388-A Coating corneal incision with protein crosslinking compound, applying extra cellular matrix material, both with carriers CHIRON OPHTHALMICS, INC. (US) 1991-10-01 US disclosed
WO-1989004172-A1 WOUND HEALING COMPOSITION AND METHOD CHIRON OPHTHALMICS INC. (US) 1989-05-18 WO disclosed